White cells called regulatory B cells could be harnessed to fight cancers and to treat autoimmune diseases by either increasing or decreasing their function, as indicated by a new research.

Is it the authors' opinion that we largely rely on infectious agents to generate the regulatory B cells that contribute not only to recovery from exacerbation of autoimmune disease, but also to ...

When your number of B cells goes down, your amount of T cells that cause inflammation goes down, too. At the same time, your level of something called regulatory T cells goes up. Regulatory T ...

Scientists at Pohang University of Science and Technology (POSTECH) and ShanghaiTech University have achieved a breakthrough ...

Aucatzyl is the first CAR-T cell therapy approved by the FDA with no requirement for a risk evaluation mitigation strategy ...

as well the maintenance of cell viability during transit and long-term follow-up requirements for up to 15 years post-trial. The regulatory nuances of radiopharmaceuticals and CAGT are complex ...

Researchers have used artificial intelligence to design thousands of new DNA switches that can precisely control the expression of a gene in different cell types. Their new approach opens the ...

The expression of MICA/B cell-surface proteins is induced by cellular stress ... or other attributes to warrant further ...

Bloomberg’s Regulatory Reporting Services is a suite of solutions for firms impacted by evolving regulatory trade and transaction reporting demands, across all markets — including buy-side ...

BeiGene's TEVIMBRA expands for cancer treatment, and BRUKINSA sales soar 107%. See why BGNE stock presents upside potential ...

The bank, which has for the past four years been operating under two regulatory reprimands ... Lananh holds a B.A. in political science from Tufts University and an M.Sc. in finance and economic ...